Elina Armstrong

Title: Elina Armstrong: Innovator in Tumor Imaging and Therapy

Introduction

Elina Armstrong is a prominent inventor based in Philadelphia, PA (US). She has made significant contributions to the field of cancer research, particularly in tumor imaging and anti-tumor therapy. With a total of 3 patents to her name, her work has the potential to impact the medical community profoundly.

Latest Patents

Among her latest patents is the invention titled "FLT4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy." This invention provides purified Flt4 receptor tyrosine kinase polypeptides and fragments, along with polynucleotides encoding such polypeptides, antibodies that specifically bind to these polypeptides, and their various uses. Another notable patent is "Antibodies to Flt4, a receptor tyrosine kinase and uses thereof," which similarly offers purified Flt4 receptor tyrosine kinase polypeptides and their applications.

Career Highlights

Elina has worked with esteemed organizations such as the Ludwig Institute for Cancer Research Limited and Helsinki University Licensing, Ltd. Her experience in these institutions has allowed her to develop innovative solutions in cancer treatment and diagnostics.

Collaborations

Elina has collaborated with notable colleagues, including Olga Aprelikova and Katri Pajusola, further enhancing her research and development efforts in the field.

Conclusion

Elina Armstrong's contributions to cancer research through her patents and collaborations highlight her role as a key innovator in the medical field. Her work continues to pave the way for advancements in tumor imaging and therapy.